{
  "ticker": "ACIU",
  "company_name": "AC Immune SA",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06891716",
      "title": "[18F]ACI-19626 PET in TDP-43 Proteinopathies",
      "status": "RECRUITING",
      "phase": "EARLY_PHASE1",
      "condition": "Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), TDP-43 Proteinopathies, Suspected Limbic Predominant Age-related TDP-43 Encephalopathy (LATE), Alzheimer's Disease (AD)",
      "start_date": "2025-01-21",
      "completion_date": "2026-11",
      "enrollment": 0,
      "sponsor": "AC Immune SA"
    },
    {
      "nct_id": "NCT04445831",
      "title": "A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Alzheimer's Disease, Cognitive Impairment, Tauopathies, Mild Cognitive Impairment, Dementia, Brain Diseases, Central Nervous System Diseases",
      "start_date": "2019-07-31",
      "completion_date": "2023-09-05",
      "enrollment": 0,
      "sponsor": "AC Immune SA"
    },
    {
      "nct_id": "NCT02738450",
      "title": "Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Down Syndrome",
      "start_date": "2016-03",
      "completion_date": "2020-06",
      "enrollment": 0,
      "sponsor": "AC Immune SA"
    },
    {
      "nct_id": "NCT04373616",
      "title": "A Study of ACI-24 in Adults With Down Syndrome",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "Down Syndrome",
      "start_date": "2021-10",
      "completion_date": "2024-10",
      "enrollment": 0,
      "sponsor": "AC Immune SA"
    },
    {
      "nct_id": "NCT05067192",
      "title": "Optimization of Morphomer-based Alpha-synuclein PET Tracers",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy, Corticobasal Degeneration, Progressive Supranuclear Palsy",
      "start_date": "2021-07-15",
      "completion_date": "2021-09-01",
      "enrollment": 0,
      "sponsor": "Skane University Hospital"
    },
    {
      "nct_id": "NCT06445465",
      "title": "Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain",
      "status": "COMPLETED",
      "phase": "EARLY_PHASE1",
      "condition": "Alpha-Synucleinopathy, Parkinson's Disease, Dementia With Lewy Bodies, Multisystem Atrophy",
      "start_date": "2020-12-24",
      "completion_date": "2024-11-26",
      "enrollment": 0,
      "sponsor": "Invicro"
    },
    {
      "nct_id": "NCT05462106",
      "title": "A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Amyloid Plaque, Beta-Amyloid, DSAD, Prodromal Alzheimer's Disease, Alzheimer's Disease",
      "start_date": "2022-06-21",
      "completion_date": "2026-06",
      "enrollment": 0,
      "sponsor": "AC Immune SA"
    },
    {
      "nct_id": "NCT06891703",
      "title": "[18F]ACI-15916 PET in \u03b1-synucleinopathies",
      "status": "RECRUITING",
      "phase": "EARLY_PHASE1",
      "condition": "Parkinson's Disease (PD), Multiple System Atrophy (MSA), Dementia With Lewy Bodies (DLB)",
      "start_date": "2025-03-20",
      "completion_date": "2026-03",
      "enrollment": 0,
      "sponsor": "AC Immune SA"
    },
    {
      "nct_id": "NCT06015841",
      "title": "A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Parkinson Disease, Parkinson Disease 6, Early-Onset",
      "start_date": "2023-07-24",
      "completion_date": "2028-01",
      "enrollment": 0,
      "sponsor": "AC Immune SA"
    }
  ],
  "summary": {
    "total_trials": 9,
    "by_phase": {
      "EARLY_PHASE1": 3,
      "PHASE1, PHASE2": 2,
      "PHASE1": 1,
      "PHASE2": 2,
      "": 1
    },
    "by_status": {
      "RECRUITING": 3,
      "COMPLETED": 4,
      "WITHDRAWN": 1,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 4,
    "completed_trials": 4,
    "conditions": [
      "Alpha-Synucleinopathy, Parkinson's Disease, Dementia With Lewy Bodies, Multisystem Atrophy",
      "Alzheimer's Disease, Cognitive Impairment, Tauopathies, Mild Cognitive Impairment, Dementia, Brain Diseases, Central Nervous System Diseases",
      "Amyloid Plaque, Beta-Amyloid, DSAD, Prodromal Alzheimer's Disease, Alzheimer's Disease",
      "Down Syndrome",
      "Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), TDP-43 Proteinopathies, Suspected Limbic Predominant Age-related TDP-43 Encephalopathy (LATE), Alzheimer's Disease (AD)",
      "Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy, Corticobasal Degeneration, Progressive Supranuclear Palsy",
      "Parkinson Disease, Parkinson Disease 6, Early-Onset",
      "Parkinson's Disease (PD), Multiple System Atrophy (MSA), Dementia With Lewy Bodies (DLB)"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:15:57.098908",
    "search_query": "AC Immune SA",
    "url": "https://clinicaltrials.gov/search?term=AC+Immune+SA"
  }
}